» Articles » PMID: 11830645

Regulation of the Tyrosine Kinase Itk by the Peptidyl-prolyl Isomerase Cyclophilin A

Overview
Specialty Science
Date 2002 Feb 7
PMID 11830645
Citations 102
Authors
Affiliations
Soon will be listed here.
Abstract

Interleukin-2 tyrosine kinase (Itk) is a nonreceptor protein tyrosine kinase of the Tec family that participates in the intracellular signaling events leading to T cell activation. Tec family members contain the conserved SH3, SH2, and catalytic domains common to many kinase families, but they are distinguished by unique sequences outside of this region. The mechanism by which Itk and related Tec kinases are regulated is not well understood. Our studies indicate that Itk catalytic activity is inhibited by the peptidyl prolyl isomerase activity of cyclophilin A (CypA). NMR structural studies combined with mutational analysis show that a proline-dependent conformational switch within the Itk SH2 domain regulates substrate recognition and mediates regulatory interactions with the active site of CypA. CypA and Itk form a stable complex in Jurkat T cells that is disrupted by treatment with cyclosporin A. Moreover, the phosphorylation levels of Itk and a downstream substrate of Itk, PLCgamma1, are increased in Jurkat T cells that have been treated with cyclosporin A. These findings support a novel mode of tyrosine kinase regulation for a Tec family member and provide a molecular basis for understanding a cellular function of the ubiquitous peptidyl prolyl isomerase, CypA.

Citing Articles

Genome-wide identification and expression analyses of and gene family under salt and heat stress in L.

Jiang Z, Zhang M, Pan J, Wu J, Yuan M Physiol Mol Biol Plants. 2024; 30(11):1871-1887.

PMID: 39687704 PMC: 11646261. DOI: 10.1007/s12298-024-01530-w.


Cyclophilin A: promising target in cancer therapy.

Jin S, Zhang M, Qiao X Cancer Biol Ther. 2024; 25(1):2425127.

PMID: 39513594 PMC: 11552246. DOI: 10.1080/15384047.2024.2425127.


"Cyclophilin A" Enzymatic Effect on the Aggregation Behavior of 1N4R Tau Protein: An Overlooked Crucial Determinant that should be Re-considered in Alzheimer's Disease Pathogenesis.

Ranjbar S, Mehrabi M, Akbari V, Pashaei S, Khodarahmi R Curr Alzheimer Res. 2024; 21(4):242-257.

PMID: 39161146 DOI: 10.2174/0115672050330163240812050223.


Inhibitors of Cyclophilin A: Current and Anticipated Pharmaceutical Agents for Inflammatory Diseases and Cancers.

Zhao X, Zhao X, Di W, Wang C Molecules. 2024; 29(6).

PMID: 38542872 PMC: 10974348. DOI: 10.3390/molecules29061235.


Proline Isomerization: From the Chemistry and Biology to Therapeutic Opportunities.

Gurung D, Danielson J, Tasnim A, Zhang J, Zou Y, Liu J Biology (Basel). 2023; 12(7).

PMID: 37508437 PMC: 10376262. DOI: 10.3390/biology12071008.


References
1.
Bunnell S, Diehn M, Yaffe M, Findell P, Cantley L, Berg L . Biochemical interactions integrating Itk with the T cell receptor-initiated signaling cascade. J Biol Chem. 2000; 275(3):2219-30. DOI: 10.1074/jbc.275.3.2219. View

2.
Heyeck S, Wilcox H, Bunnell S, Berg L . Lck phosphorylates the activation loop tyrosine of the Itk kinase domain and activates Itk kinase activity. J Biol Chem. 1997; 272(40):25401-8. DOI: 10.1074/jbc.272.40.25401. View

3.
Yang W, Collette Y, Nunes J, Olive D . Tec kinases: a family with multiple roles in immunity. Immunity. 2000; 12(4):373-82. DOI: 10.1016/s1074-7613(00)80189-2. View

4.
Pawson T, Nash P . Protein-protein interactions define specificity in signal transduction. Genes Dev. 2000; 14(9):1027-47. View

5.
Ching K, Grasis J, Tailor P, Kawakami Y, Kawakami T, Tsoukas C . TCR/CD3-Induced activation and binding of Emt/Itk to linker of activated T cell complexes: requirement for the Src homology 2 domain. J Immunol. 2000; 165(1):256-62. DOI: 10.4049/jimmunol.165.1.256. View